Literature DB >> 92525

Primary in vitro cytotoxic response of NZB spleen cells to Qa-1b-associated antigenic determinants.

R R Rich, D A Sedberry, D L Kastner, L Chu.   

Abstract

We have shown that cytotoxic lymphocytes generated in primary cultures of NZB spleen cells with H-2-identical BALB/c or B10.D2 stimulator cells exhibit specificity for Qa-1b-associated antigenic determinants. This unidirectional cytotoxicity constitutes the initial demonstration of a primary in vitro response to antigens of the Qa-Tla system. Such responses do not require H-2 homology between effector and target cells in the assay system. In fact, when H-2Dd homologous target cells were employed there was little, if any, evidence for development of primary H-2-restricted responses to minor locus histocompatibility antigens or viral antigens. In view of the recently defined role of Qa-1+, Ly-1,2,3+ cells as regulators of antibody responses, and of the deficiency of such cells in NZB mice, the observation of hyperreactivity for determinants of this system may be relevant to the development of autoimmunity in these animals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92525      PMCID: PMC2185726          DOI: 10.1084/jem.150.6.1555

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.

Authors:  L J OLD; E A BOYSE
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

2.  Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells.

Authors:  A N Theofilopoulos; D L Shawler; D H Katz; F J Dixon
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

3.  The H(Tla) histocompatibility locus: a study of in vitro lymphocyte reactivity.

Authors:  M B Widmer; D J Schendel; F H Bach; E A Boyse
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

4.  Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.

Authors:  G J Hämmerling; U Hämmerling; L Flaherty
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

5.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

6.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

7.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

8.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

9.  Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

Authors:  H Cantor; L McVay-Boudreau; J Hugenberger; K Naidorf; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex.

Authors:  U Botzenhardt; J Klein; M Ziff
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  13 in total

1.  Primary cytotoxic T-cell response in vitro against Mls antigens in NZB-mice.

Authors:  U Botzenhardt; J Müller-Quernheim
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex.

Authors:  J Klein; F Figueroa; C S David
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  Genetic control of B- and T-lymphocyte abnormalities of NZB mice in crosses with B10.D2 mice.

Authors:  W F Davidson; T M Chused; H C Morse
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Chromosome 1 locus required for induction of CTL to H-2-compatible cells in NZB mice.

Authors:  W F Davidson; B J Mathieson; C A Kozak; T M Chused; H C Morse
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

5.  Genetic and functional analyses of the primary in vitro CTL: response of NZB lymphocytes to H-2-compatible cells.

Authors:  W F Davidson; T M Chused; H C Morse
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

6.  T-cell hyperreactivity of NZB mice against H-2 identical cells. Equal cytotoxic T lymphocyte precursor frequency against H-2 allogeneic and H-2 syngeneic target cells in NZB.

Authors:  J Müller; R Bartlett; U Botzenhardt
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

7.  Tissue graft rejection in murine models of autoimmune disease.

Authors:  J Schultz; R Demott-Friberg; S Walker; T F Beals
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  Primary cell-mediated lympholysis response to a maternally transmitted antigen.

Authors:  R Smith; D P Huston; R R Rich
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  NZB cytotoxic lymphocyte responses. Kinetic analyses.

Authors:  D P Huston; A D Steinberg
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Maternally transmitted target antigen for unrestricted killing by NZB T lymphocytes.

Authors:  K Fischer Lindahl; M Bocchieri; R Riblet
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.